D.A. Napalkov, A.S. Panferov
Anemic Syndrome In Patients With Chronic Heart Failure
|
№15 / 2011
|
V.V. Fomin
Omega-3 Polyunsaturated Fatty Acids: Towards A Status Of Self-directed Strategy For Improving The Cardiovascular Prognosis
|
№14 / 2011
|
A.A. Pulin, T.V. Kustov, V.V. Fomin
Loop Diuretics: Whether The Well-established Standard Of Care Needs Reform?
|
№14 / 2011
|
L.I.Dvoretsky, N.V. Dyatlov
Anemia In Patients With Chronic Heart Failure
|
№14 / 2011
|
N.A. Kosheleva, A.P. Rebrov
Features Of Heart And Vascular Remodeling In Patients With Stable Angina And Chronic Heart Failure During 6-month Treatment With Ivabradine
|
№13 / 2010
|
D. Napalkov, N. Seidova
New Options For Beta-adrenoblockers Use: Specific Carvedilol's Properties
|
№11 / 2010
|
S. Gilyarevsky, I.Kuzmina
Clinical And Statistical Significance Of Results Of Clinical Tests As Criteria For The Beta-blocker Selection For The Treatment Of Chronic Heart Failure
|
№8 / 2010
|
E. Averin, S. Chernova
Correlation Of Cardiohemodynamics Indices, Inflammatory Cytokines Levels And Depressive Disorders In Patients With Chronic Heart Failure
|
№7 / 2010
|
Adamchik A.S., Kruchkova I.V.
Possibilities For The Correction Of Carbohydrate Metabolism Disturbances And 24 Hours Blood Pressure Profile In Patients With Chronic Heart Insufficiency And Metabolic Syndrome
|
№15 / 2009
|
A.B. Strok, Yu.B. Belousov
Algorithm Of Diuretics Prescription In Chronic Heart Failure: Diuver As Loop Diuretic Of New Generation
|
№11 / 2009
|
O.A. Maneshina, Yu.B. Belousov С. 1519
Nonselective Beta-adrenoblocker Carvedilol With Vasodilating Properties In The Therapy Of Cardiovascular Diseases
|
№10 / 2009
|
V.I. Makolkin
In Spite Of Criticism, Beta- Beta-blockers Remain Preparations Of Selection In The Treatment Of The Cardiovascular Diseases
|
№6 / 2009
|